Maven Securities LTD Applied Therapeutics Inc. Transaction History

Maven Securities LTD

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$1.84 - $3.35 $92,000 - $167,500
50,000 New
50,000 $167,000
Q2 2022

Aug 15, 2022
BUY
$0.76 - $2.64 $38,000 - $132,000
50,000 New
50,000 $47,000
Q2 2021

Aug 16, 2021
SELL
$14.05 - $25.04 $702,500 - $1.25 Million
-50,000 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$16.57 - $28.65 $828,500 - $1.43 Million
50,000 New
50,000 $950,000

Others Institutions Holding APLT

# of Institutions
140
Shares Held
112M
Call Options Held
1.68M
Put Options Held
1.91M
View Full List

About Applied Therapeutics Inc.

APLT Quotes by TradingView
  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $34.1M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email